The report " Sunitinib Malate Market Forecast for Pancreatic Cancer, 2016-2017, G7 Countries, (U.S., Germany, France, U.K., Italy, Spain, Japan)", The sunitinib malate market for pancreatic cancer is projected to reach USD 76.7 Million by 2021, at a CAGR of 13.9% from 2016 to 2021.
Browse 14 market data Tables spread through 26 Pages and in-depth TOC on "Sunitinib Malate Market Forecast for Pancreatic Cancer, 2016-2017, G7 Countries, (U.S., Germany, France, U.K., Italy, Spain, Japan)"
http://www.marketsandmarkets.com/Market-Reports/sunitinib-malate-market-194614514.html
Early buyers will receive 10% customization on reports.
Industry Insights:
A number of factors, such as increasing incidence of pancreatic cancer, availability of a limited number of drug therapeutic options for the treatment of advanced pancreatic neuroendocrine tumors, and poor diagnosis rate in the early stages of pancreatic cancer are driving the demand of sunitinib malate in the treatment of pancreatic cancer.
Also, the overall number of patients who are eligible for taking sunitinib malate is expected to grow at a high CAGR during the forecast period.
Get The PDF Brochure For This Report:
http://www.marketsandmarkets.com/pdfdownload.asp?id=194614514
Geographical Scenario:
Based on geography, the market is segmented into seven country-level segments, namely, the U.S., Germany, France, the U.K., Italy, Spain, and Japan. The U.S. is expected to dominate this market primarily due to the higher number of patients suffering from pancreatic cancer in the country.
However, the market in the U.K. is expected to witness the highest growth rate during the forecast period.
Request Sample:
http://www.marketsandmarkets.com/requestsample.asp?id=152603894
Industry Leaders:
The U.S. is the largest market for sunitinib malate for the treatment of pancreatic cancer, followed by Japan and Germany. Growth in the U.S. market is primarily driven by the higher incidence of pancreatic cancer and the growing adoption of sunitinib malate for pNET treatment.
Target Audience
• Pharmaceutical Companies
• CROs
• Hospitals
• Oncology Centers
• Health Insurance Payers
• Regulatory Authorities
• Medical Oncologists
• Oncology Registries
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441
Sunitinib Malate Market Analysis- opportunities sales, revenue, Gross Margin, Outlook and Forecast T
Company: Markets and Markets
Contact Name: Sudhir H Malekar
Contact Email: Sandeep.guha28@gmail.com
Contact Phone: 0000000000
Contact Name: Sudhir H Malekar
Contact Email: Sandeep.guha28@gmail.com
Contact Phone: 0000000000